2. Каратеев А.Е., Насонов Е.Л., Ивашкин В.Т. с соавт. Рациональное использование нестероидных противовоспалительных препаратов. Клинические рекомендации. Научно-практическая ревматология. 2018; 56 (прил. 1): 1–29.

3. Maher C., Underwood M., Buchbinder R. Non-specific low back pain. Lancet. 2017;389(10070): 736–47. doi: 10.1016/S0140-6736(16)30970-9.

4. Qaseem A., Wilt T.J., McLean R.M. et al. Noninvasive treatments for acute, subacute, andchronic low back pain: A clinical practice guideline from the American College of Physicians.Ann Intern Med. 2017; 166(7): 514–30. doi: 10.7326/M16-2367.

5. Roelofs P.D., Deyo R.A., Koes B.W. et al. Non-steroidal anti-inflammatory drugs for low backpain. Cochrane Database Syst Rev. 2008; 1: CD000396. doi: 10.1002/14651858.CD000396.pub3.

6. http://grls.rosminzdrav.ru (date of access – 01.10.2020).

7. Bjordal J., Klovning A., Ljunggren A., Slordal L. Short-term efficacy of pharmacotherapeuticinterventions in osteoarthritic knee pain: A meta-analysis of randomised placebo-controlledtrials. Eur J Pain. 2007; 11(2): 125–38. doi: 10.1016/j.ejpain.2006.02.013.

8. Daniels S.E., Bandy D.P., Christensen S.E. et al. Evaluation of the dose range of etoricoxib in anacute pain setting using the postoperative dental pain model. Clin J Pain. 2011; 27(1): 1–8. doi:10.1097/AJP.0b013e3181ed0639.

9. DeLemos B., Xiang J., Benson C. et al. Tramadol hydrochloride extended-release once-daily inthe treatment of osteoarthritis of the knee and/or hip: a double-blind, randomized, doserangingtrial. Am J Ther. 2011; 18(3): 216–26. doi: 10.1097/MJT.0b013e3181cec307.

10. Innes G., Croskerry P., Worthington J. et al. Ketorolac versus acetaminophen-codeine in theemergency department treatment of acute low back pain. J Emerg Med. 1998 Jul; 16(4): 549–56.doi: 10.1016/S0736-4679(98)00044-4.

11. O'Donnell J.B., Ekman E.F., Spalding W.M. et al. The effectiveness of a weak opioid medicationversus a cyclo-oxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug in treatingflare-up of chronic low-back pain: results from two randomized, double-blind, 6-week studies. JInt Med Res. 2009; 37(6): 1789–802. doi: 10.1177/147323000903700615.

12. Derry S., Moore R.A. Single dose oral celecoxib for acute postoperative pain in adults. Cochrane Database Syst Rev. 2013; 10: CD004233. doi: 10.1002/14651858.CD004233.pub4.

13. Moore A., Makinson G., Li C. Patient-level pooled analysis of adjudicated gastrointestinal outcomes in celecoxib clinical trials: meta-analysis of 51,000 patients enrolled in 52 randomized trials. Arthritis Res Ther. 2013; 15(1): R6. doi: 10.1186/ar4134.

14. Trelle S., Reichenbach S., Wandel S. et al. Cardiovascular safety of non-steroidal antiinflammatory drugs: network meta-analysis. BMJ. 2011; 342: c7086. doi: 10.1136/bmj.c7086.

15. Nissen S.E., Yeomans N.D., Solomon D.H. et al. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med. 2016; 375(26): 2519–29. doi: 10.1056/ NEJMoa1611593.

16. Barkin R.L., Beckerman M., Blum S.L. et al. Should nonsteroidal anti-inflammatory drugs (NSAIDs) be prescribed to the older adult? Drugs Aging. 2010; 27(10): 775–89. doi: 10.2165/11539430-000000000-00000.

17. Инструкция по применению препарата Трамал ретард. РУ: П N014665/01. Доступ: http:// grls.rosminzdrav.ru (дата обращения – 01.10.2020).

18. Derry S., Moore R.A., Gaskell H. et al. Topical NSAIDs for acute musculoskeletal pain in adults. Cochrane Database Syst Rev. 2015; 6: CD007402. doi: 10.1002/14651858.CD007402. pub3.

19. Бадокин В. Значение локальной терапии НПВП в клинической практике. Врач. 2012; 4: 81–85.

20. Oliveira C.B., Maher C.G., Pinto R.Z. et al. Clinical practice guidelines for the management of non-specific low back pain in primary care: an updated overview. Eur Spine J. 2018; 27(11): 2791–803. doi: 10.1007/s00586-018-5673-2.

21. Yaksi A., Ozgonenel L., Ozgonenel B. The efficiency of gabapentin therapy in patients with lumbar spinal stenosis. Spine (Phila Pa 1976). 2007; 32(9): 939–42. doi: 10.1097/01. brs.0000261029.29170.e6.